SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-22-000045
Filing Date
2022-11-08
Accepted
2022-11-08 09:03:52
Documents
78
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20220930.htm   iXBRL 10-Q 3018240
2 EX-10.1 rprx-20220930ex101.htm EX-10.1 149316
3 EX-10.2 rprx-20220930ex102.htm EX-10.2 150149
4 EX-10.3 rprx-20220930ex103.htm EX-10.3 299532
5 EX-31.1 rprx-20220930ex311.htm EX-31.1 9359
6 EX-31.2 rprx-20220930ex312.htm EX-31.2 9395
7 EX-32 rprx-20220930ex32.htm EX-32 5120
  Complete submission text file 0001802768-22-000045.txt   12269847

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20220930.xsd EX-101.SCH 69334
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20220930_cal.xml EX-101.CAL 95423
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20220930_def.xml EX-101.DEF 400447
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20220930_lab.xml EX-101.LAB 725547
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20220930_pre.xml EX-101.PRE 503780
72 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20220930_htm.xml XML 2412601
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 221367435
SIC: 2834 Pharmaceutical Preparations